A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing
Appl Health Econ Health Policy
.
2013 Feb;11(1):79-82.
doi: 10.1007/s40258-012-0008-7.
Authors
Brian Godman
,
Lars L Gustafsson
PMID:
23322546
DOI:
10.1007/s40258-012-0008-7
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug Costs / standards*
Drug Industry / economics*
Economics, Pharmaceutical*
Humans
Reimbursement, Incentive / economics*